Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ricardo Mouzo Mirco
Use of Paricalcitol in stage Vd Chronic Kidney Disease patients using a permanent catheter due to haemodialysis; over the effect of inflammatory and oxidative stress parameters. This study uses paricalcitol (vitamin D) versus atorvastatin versus paricalcitol plus atorvastatin treatments.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Vd CKD patients using haemodialysis during 3 or more months.
Tunnelized-bearer permanent catheters on haemodialysis at last 6 months previous at the beginning of the study. .
Kt stable, over 45 litres on both sexs.
Patients in treatment wiht atorvastatin
Patients without infectious or inflammatory processes over 8 weeks.
Two consecutive PTH \< than 400 pg/ml; Ca\<10.2 and P \<7.0 mg/dl.
You may not be if
Patients \> 18 years.
Pregnant women.
Patients hospitalized 4 weeks before the beginning of the treatment.
